Table 2 Primer sequences.

From: Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR

Exon

Name

Sequence (5’-3’)

Modifications

Target

Primers for Exon amplification

Exon 19

Tag1-19del

TCCCGCGAAATTAATACGACAAGTTAAAATTCCCGTCGCTATC

 

EGFR exon 19

 

Tag2-19del

GCTGGAGCTCTGCAGCTAGACCCCCACACAGCAAAG

 

EGFR exon 19

Exon 20

Tag1-T790M

TCCCGCGAAATTAATACGACGCATCTGCCTCACCTCCAC

 

EGFR exon 20

 

Tag2-T790M

GCTGGAGCTCTGCAGCTAAGCAGGTACTGGGAGCCAAT

 

EGFR exon 20

Exon 21

Tag1-L858R

TCCCGCGAAATTAATACGACAGCCAGGAACGTACTGGTGA

 

EGFR exon 21

 

Tag2-L858R

GCTGGAGCTCTGCAGCTATGCCTCCTTCTGCATGGTAT

 

EGFR exon 21

Emulsion PCR primers

 

Tag1-F

TCCCGCGAAATTAATACGAC

  
 

Tag2-R

GCTGGAGCTCTGCAGCTA

  

Hybridization probe for BEAMing

Exon 19

19del_35_49_Cy5

GGAGATGTTTTGATAGCG

5′ Cy5

exon 19 E746-A750del

 

19del_36_50_Cy5

CGGAGATGTCTTGATAGC

5′ Cy5

exon 19 E746-A750del

 

19del_40_57 Cy5

TGGCTTTCGATTCCTTGA

5′ Cy5

exon 19 L747-S752del.P753S

 

19del_AATTCC_ Cy5

TGTTGCTTCTCTTGGAATT

5′ Cy5

exon 19 E746-L747del.IP

 

19del_36_55_T_ Cy5

GCTTTCGGAACCTTGATAG

5′ Cy5

exon 19 L747-S752del. E746V

 

19del_35_53_ACT_ Cy5

GGAGAAGTTTTGATAGCG

5′ Cy5

exon 19 K745-E749del.A750K

 

19del_39_56_CAG_ Cy5

TTTCGGCTGTTCCTTGAT

5′ Cy5

exon 19 L747-T751del.S752Q

 

19del_39_48_C_ Cy5

GAGATGTTGGTTCCTTGAT

5′ Cy5

exon 19 L747-E749del.A750P

 

19del_WT_488

TGTTGCTTCTCTTAATTCC

5′ Alexa488

exon 19 wild-type control

Exon 20

T790M_Mut- Cy5

atgagctgcAtgatgag

5′ Cy5

T790M mutation

 

T790M_WT-488

tgagctgcGtgatgag

5′ Alexa488

Wild-type control for T790M

Exon 21

L858R_Mut_LNA_ Cy5

gtttggccCgcccaaaat

5′ Cy5

L858R mutation

 

L858R_WT_LNA_488

gtttggccAgcccaaaat

5′ Alexa488

Wild-type control for L858R

 

L861Q_Mut_Cy5

cacccagcTgtttggcc

5′ Cy5

L861Q mutation

 

L861Q_WT_488

cacccagcAgtttggcc

5′ Alexa488

Wild-type control for L861Q